PPA
ATRS

Parametric Portfolio Associates’s Antares Pharma, Inc. ATRS Stock Holding History

Parametric Portfolio Associates’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.09M Buy
264,913
+95,334
+56% +$346K ﹤0.01% 2748
2021
Q4 		$605K Buy
169,579
+22,814
+16% +$79.8K ﹤0.01% 2989
2021
Q3 		$534K Buy
146,765
+17,292
+13% +$69.9K ﹤0.01% 3081
2021
Q2 		$565K Buy
129,473
+56,842
+78% +$232K ﹤0.01% 3028
2021
Q1 		$299K Buy
72,631
+16,079
+28% +$69.7K ﹤0.01% 3719
2020
Q4 		$226K Buy
56,552
+880
+2% +$2.85K ﹤0.01% 3720
2020
Q3 		$150K Buy
55,672
+12,385
+29% +$34.3K ﹤0.01% 3729
2020
Q2 		$119K Sell
43,287
-26,311
-38% -$73.4K ﹤0.01% 3749
2020
Q1 		$164K Sell
69,598
-247,290
-78% -$841K ﹤0.01% 3607
2019
Q4 		$1.49M Buy
316,888
+227,979
+256% +$933K ﹤0.01% 2861
2019
Q3 		$297K Buy
88,909
+10,314
+13% +$34K ﹤0.01% 3544
2019
Q2 		$259K Sell
78,595
-37,066
-32% -$107K ﹤0.01% 3634
2019
Q1 		$350K Sell
115,661
-665
-0.6% -$2.15K ﹤0.01% 3493
2018
Q4 		$316K Buy
116,326
+105,187
+944% +$346K ﹤0.01% 3501
2018
Q3 		$37K Sell
11,139
-6,367
-36% -$19.7K ﹤0.01% 3922
2018
Q2 		$45K Buy
17,506
+847
+5% +$2.11K ﹤0.01% 3856
2018
Q1 		$37K Buy
16,659
+3,457
+26% +$7.78K ﹤0.01% 3914
2017
Q4 		$26K Buy
+13,202
New +$28.7K ﹤0.01% 3890

Other funds holding ATRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

Parametric Portfolio Associates's ATRS Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Antares Pharma, Inc. (ATRS) stake by 56% in Q1 2022, buying an estimated $346K and bringing the position to 264,913 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2748.

Parametric Portfolio Associates first reported a position in ATRS in Q4 2017 and has held it in 18 quarters since. The position peaked at $1.49M in Q4 2019. 177 funds tracked by Wall St. Rank hold ATRS as of Q1 2022.

  • Parametric Portfolio Associates held 264,913 shares of Antares Pharma, Inc. worth $1.09M as of Q1 2022.
  • Parametric Portfolio Associates bought 95,334 Antares Pharma, Inc. shares in Q1 2022, an estimated $346K.
  • Antares Pharma, Inc. made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2748 holding.
  • Parametric Portfolio Associates first reported a position in Antares Pharma, Inc. in Q4 2017 and has held it in 18 quarters since.
  • Parametric Portfolio Associates's Antares Pharma, Inc. position peaked at $1.49M in Q4 2019.
  • 177 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.